psalexa

Nebulizer Market To Generate Revenue Worth $1,698.1 Million by 2030

Published Date:   September 2020

The increasing air pollution levels, growing geriatric population, rising healthcare expenditure, increasing usage of cigarettes, surging cases of respiratory diseases, and easy availability of portable devices of key players are the major growth drivers for the global nebulizer market. As a result of these factors, the industry revenue stood at $765.1 million in 2019, and it is set to rise to $1,698.1 million by 2030, exhibiting a CAGR of 7.4% during the forecast period (2020–2030).

The nebulizer market has seen growth in 2020 due to the rising number of COVID-19 patients across the world, which has increased the demand for nebulizers globally. Moreover, many companies across the world have increased their manufacturing capacities to meet the demand for these products, as COVID-19 primarily attacks the lungs, thus hampering the ability to breathe.

Portable Is Larger and Faster-Growing Category in Nebulizer Market

Based on portability, the global nebulizer market is bifurcated into portable and stand-alone categories. Of these, the portable nebulizer category dominated the market in 2019, and it is also expected to experience the faster growth during the forecast period. The geriatric population requires extra convenience and comfort during treatment and demands more-advanced drug delivery methods, which is fueling the demand for portable nebulizers across the world.

Further, the nebulizer market is classified into pneumatic, ultrasonic, and mesh, on the basis of product type. Among these, the pneumatic category dominated the global market during the historical period (2014–2019), mainly owing to the advanced features of these variants, including high durability, a range of medicine particle sizes, lesser drug loss, and dosing control. Pneumatic nebulizers are further categorized into vented and breath-actuated, on the basis of type.

Globally, the North American region held the largest share in the nebulizer market in 2019. The region is further expected to dominate the market during the forecast period. This is mainly due to the huge number of COVID-19 patients, high healthcare expenditure, and high prevalence of other respiratory diseases. Furthermore, the launch of advanced products by various players, such as Briggs Healthcare, Allied Healthcare Products Inc., and Koninklijke Philips N.V., boosts the growth of the regional market.

Key Players Creating Lucrative Business Opportunities with Strategic Partnerships and Mergers

Players in the nebulizer market are consistently focusing on strategic business partnerships and mergers to remain competitive. For instance, in June 2020, AireHealth Inc. announced a merger agreement with BreathResearch Inc. AireHealth Inc. offers portable nebulizers, which pair with a smartphone app for remote monitoring. With this, the former company aims to strengthen its capabilities by combining the latter’s assets, including employees, intellectual property, research, published works, and patents related to respiratory drug delivery, medication adherence, and breathing sound analysis solutions, which use machine learning and artificial intelligence, with its own.

Similarly, in May 2020, Aerogen Ltd. entered into a distribution partnership with Eximia Medical S.R.L., which supplies infant and adult respiratory care equipment in Romania. Through this partnership, the former company can offer its products and services in a better way, along with utilizing the experience of Eximia Medical S.R.L. in providing better consultation on selecting and installing products; the company offers training, maintenance, and backup services.

Some of the major players operating in the global nebulizer market are Allied Healthcare Products Inc., Aerogen Ltd., Briggs Healthcare, OMRON Corporation, Rossmax Swiss GmbH, Beurer GmbH, GF Health Products Inc., PARI GmbH, Vectura Group plc, Becton, Dickinson and Company, General Electric Company, Agilent Technologies Inc., and Koninklijke Philips N.V.